Evidence map›Paper›PMID 35630529›Full record

ArticleMolecules (Basel, Switzerland)2022

Comparative Metabolomic Analysis of Four Fabaceae and Relationship to In Vitro Nematicidal Activity against

Lise Negrel, Raymonde Baltenweck, Gerard Demangeat, Françoise Le Bohec-Dorner, Camille Rustenholz, Amandine Velt, Claude Gertz, Eva Bieler, Markus Dürrenberger, Pascale Gombault and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Lise NegrelMultifolia, 10408 Viâpres-le-Petit, France.
Raymonde BaltenweckSanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.ORCID 0000-0002-8228-1517
Gerard DemangeatSanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.
Françoise Le Bohec-DornerSanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.
Camille RustenholzSanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.
Amandine VeltSanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.ORCID 0000-0003-2368-839X
Claude GertzSanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.
Eva BielerNano Imaging Laboratory, Swiss Nanoscience Institute, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland.
Markus DürrenbergerNano Imaging Laboratory, Swiss Nanoscience Institute, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland.
Pascale GombaultMultifolia, 10408 Viâpres-le-Petit, France.
Philippe HugueneySanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.
Olivier LemaireSanté de la Vigne et Qualité du Vin, INRAE, Université de Strasbourg, 68000 Colmar, France.
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The grapevine fanleaf virus (GFLV), responsible for fanleaf degeneration, is spread in vineyards by the soil nematode

Indexed as

LotusNematodaAnimalsAntinematodal AgentsHumansPlant DiseasesSoilAntinematodal AgentsSoilFabaceaegrapevine fanleaf degenerationLotusMelilotusmetabolomicsnematicidenematodeOnobrychisTrifoliumXiphinema index

Identifiers

PMID35630529
PMCPMC9146138
OpenAlexW4280649378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.